MITO
Stealth BioTherapeutics Corp. ADS
MITO
MITO
Delisted
MITO was delisted on the 15th of November, 2022.
10 hedge funds and large institutions have $947K invested in Stealth BioTherapeutics Corp. ADS in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+5
Holders Change %
+100%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
PM
Prosight Management
Dallas,
Texas
|
$417K |
2 |
Renaissance Technologies
New York
|
$158K |
3 |
Millennium Management
New York
|
$45K |
4 |
PC
PA Capital
Richmond,
Virginia
|
$28K |
5 |
Two Sigma Investments
New York
|
$15K |
Top Sellers
1 |
UBS Group
Zurich,
Switzerland
|
$1K |
2 |
Morgan Stanley
New York
|
$7K |